BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2185054)

  • 1. Interactions between endogenous and exogenous insulin and human pancreatic polypeptide secretion.
    Zandomeneghi R; Luciani A; Massari M; Montanari P; Poppi C; Pavesi C; Serra L
    Diabete Metab; 1990; 16(1):21-5. PubMed ID: 2185054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the pancreatic polypeptide response to hypoglycemia in man.
    Zulueta MA; Vincent E; Correas I; Villanueva ML; Felíu JE; Marco J
    Diabete Metab; 1982 Mar; 8(1):47-51. PubMed ID: 7047252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of pancreatic polypeptide secretion by glucose in man.
    Marco J; Hedo JA; Villanueva ML
    J Clin Endocrinol Metab; 1978 Jan; 46(1):140-5. PubMed ID: 752016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA; Vinik AI; Levitt N
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
    Hedo JA; Villanueva ML; Marco J
    J Clin Endocrinol Metab; 1978 Aug; 47(2):366-71. PubMed ID: 400718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man.
    Seymour NE; Brunicardi FC; Chaiken RL; Lebovitz HE; Chance RE; Gingerich RL; Elahi D; Andersen DK
    Surgery; 1988 Aug; 104(2):119-29. PubMed ID: 3041640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal profile of plasma motilin concentrations during fasting and feeding in man.
    Funakoshi A; Ho LL; Jen KL; Knopf R; Vinik AI
    Gastroenterol Jpn; 1985 Oct; 20(5):446-56. PubMed ID: 3908210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of adrenergic receptor blockade on the exercise-induced rise in pancreatic polypeptide in man.
    Berger D; Floyd JC; Lampman RM; Fajans SS
    J Clin Endocrinol Metab; 1980 Jan; 50(1):33-9. PubMed ID: 7350185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polypeptide (PP) responses to oral and intravenous glucose in man.
    Sive AA; Vinik AI; van Tonder SV
    Am J Gastroenterol; 1979 Feb; 71(2):183-5. PubMed ID: 433901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous administration of insulin and tolbutamide. A mathematical simulation on the different glycolytic activity in the organism (author's transl)].
    Geiseler D; Schmüling R
    Arzneimittelforschung; 1979; 29(5):823-7. PubMed ID: 582980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic polypeptide response to exercise. Effect of alanine and glucose ingestion in carbohydrate-starved athletes.
    Koeslag JH; Levinrad LI; Klaff LJ
    S Afr Med J; 1985 Jun; 67(22):884-7. PubMed ID: 3890217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid overexposure in neonatal life alters pancreatic beta-cell function in newborn foals.
    Jellyman JK; Allen VL; Holdstock NB; Fowden AL
    J Anim Sci; 2013 Jan; 91(1):104-10. PubMed ID: 23100584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of bombesin on glucose- and tolbutamide-induced insulin release in man.
    Scarpignato C; Gioffré M; Gulino FM; Micali B
    Br J Pharmacol; 1988 Aug; 94(4):1023-8. PubMed ID: 3061541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of glucose, tolbutamide, and arginine on C-peptide release during remission in type I diabetes mellitus.
    Vetter U; Heinze E; Thon A; Beischer W; Teller W
    Eur J Pediatr; 1983 Sep; 140(4):305-10. PubMed ID: 6354722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the effect of intravenous infusion of glucose and tolbutamide on the insulin delivery rate in man.
    Asano T; Sasaki H; Okumura M
    Diabetologia; 1978 Sep; 15(3):159-64. PubMed ID: 700280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pancreatic polypeptide: studies in fasting and in the growth hormone deficient state.
    Loo SW; Gabbay KH; Merimee TJ
    Horm Metab Res; 1980 Aug; 12(8):361-3. PubMed ID: 6997163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of human pancreatic polypeptide secretion by hypoglycemia is independent of adrenergic mechanisms.
    Rizza R; Go V; Cryer P; Verdonk C; Gerich J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1234-6. PubMed ID: 6752172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma pancreatic polypeptide concentrations in acute pancreatitis.
    Sive AA; Vinik AI; Barbezat GO; Schwartz TW
    S Afr Med J; 1980 Jun; 57(25):1047-9. PubMed ID: 7404090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.